Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q1 2023 Earnings

11MayExpected

Q2 2022

Q3 2022

Q4 2022

Q1 2023

-6.75

-4.56

-2.37

-0.18

Details

Expected EPS

-0.18

Actual EPS

-4.55

Surprise EPS

-4.37

Surprise Percent

+2,427.78%

Description

Spyre Therapeutics (SYRE) has reported earnings of -4.55 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.